Similar Articles
561 Worldwide management of hepatocellular carcinoma during the COVID-19 pandemic
562 Application of radiomics in hepatocellular carcinoma: A review
563 Trial eligibility in advanced hepatocellular carcinoma: Does it support clinical practice in underrepresented subgroups?
564 Non-cirrhotic hepatocellular carcinoma in chronic viral hepatitis: Current insights and advancements
565 High rate of complete histopathological response in hepatocellular carcinoma patients after combined transarterial chemoembolization and stereotactic body radiation therapy
566 Role of chromosome 1q copy number variation in hepatocellular carcinoma
567 Distant metastasis of hepatocellular carcinoma to Meckel’s cave and cranial nerves: A case report and review of literature
568 Oncogenic tuftelin 1 as a potential molecular-targeted for inhibiting hepatocellular carcinoma growth
569 Best practices for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis
570 Serum vascular endothelial growth factor as a tumor marker for hepatocellular carcinoma in hepatitis C virus-related cirrhotic patients
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA